What is the recommended follow-up for an esophageal polyp with a pathology of squamous papilloma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Follow-up Recommendations for Esophageal Squamous Papilloma

Endoscopic surveillance with repeat endoscopy in 6-12 months is recommended for patients with esophageal squamous papilloma, followed by annual surveillance if no recurrence is observed. 1

Understanding Esophageal Squamous Papilloma

Esophageal squamous papilloma (ESP) is a rare benign epithelial tumor of the esophagus that is typically discovered incidentally during endoscopy performed for other indications. While generally considered benign, proper follow-up is important to monitor for potential recurrence or, in rare cases, malignant transformation.

Recommended Follow-up Protocol

Based on the most recent guidelines, the following approach is recommended:

  1. Initial follow-up endoscopy: 6-12 months after initial diagnosis and removal 1
  2. Subsequent surveillance: Annual endoscopic examination if no recurrence is observed 1
  3. Duration of surveillance: At least 2 years, with consideration for longer follow-up in high-risk patients

Endoscopic Examination Technique

During follow-up endoscopy:

  • Perform careful inspection of the entire esophageal mucosa
  • Take multiple biopsies of any suspicious areas or mucosal abnormalities
  • Document the location, size, and appearance of any new lesions

Management of Recurrence

If recurrence is detected:

  • Complete endoscopic removal is recommended using either:
    • Endoscopic mucosal resection (EMR)
    • Removal by biopsy forceps for smaller lesions (<3mm)
    • Diathermic snare for larger lesions (>3mm) 2
  • Histopathological examination of all removed tissue

Risk Stratification

While most ESPs have low malignant potential, certain factors may warrant more vigilant surveillance:

  • Higher risk factors:
    • Multiple or larger papillomas
    • Evidence of HPV infection, particularly high-risk types 3
    • Concurrent Barrett's esophagus or other precancerous conditions
    • Persistent gastroesophageal reflux disease

Clinical Considerations

  • ESPs are generally considered benign with low malignant potential 4
  • Complete endoscopic removal is both diagnostic and therapeutic 5
  • Some studies suggest that follow-up may be unnecessary due to the benign nature of these lesions 4, but more recent guidelines recommend surveillance to ensure complete removal and monitor for recurrence 1

Common Pitfalls

  1. Inadequate initial removal: Ensure complete excision during the initial procedure to minimize recurrence
  2. Missing multiple lesions: Thoroughly examine the entire esophagus as papillomas can be multiple
  3. Overlooking underlying conditions: Address potential contributing factors such as gastroesophageal reflux disease
  4. Insufficient biopsy sampling: Take adequate biopsies of any suspicious areas to rule out dysplasia or early malignancy

By following these recommendations, clinicians can provide appropriate surveillance while avoiding unnecessary procedures for patients with esophageal squamous papilloma.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Esophageal squamous papilloma - a case report].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.